News About: Pharm. Industry
Bayer Korea OTC Business Starts New Year under New Management
The Consumer Care Division of Bayer Korea will start the new year with its recent acquisition of over-the-counter (OTC) products from Roche Korea, under a new management of Director Kang Sung-chae, who previously mana...
Hanseo Submitted Five International Patent Filings for Its Liver Medication
Hanseo Pharm Co. Ltd. recently announced the patent filings of its novel medication HS0406, for the treatment of cirrhosis, to the United States, Japan, China, Russia, and Germany.
Hanseo Pharm, which was newly lis...
CJ Surpasses Annual Production of IV Solutions Over 30 Million Units
CJ Pharmaceutical Division achieved its annual production of intravenous (IV) fluid sets and solutions surpassing 30 million units per year, driving the total IV solution revenue of 40 billion won for the current year...
Local Manufacturers Achieved $23 Million Worth of Contracts at CPhl Worldwide 2004The Korea Pharmaceutical Traders Association (KPTA) recently announced the successful results from participating CPhl Worldwide 2004, an international convention of pharmaceutic...
|
Kuhnil Signs Exclusive Marketing Rights for Senju’s Bronuck
Kuhnil Pharmaceutical recently acquired the exclusive domestic marketing rights for Bronuck (bromfenac sodium hydrate), an ophthalmic solution manufactured by Japan’s Senju Pharmaceuticals Co. Ltd.
Bronuck is a top...
Elidel’s Claim on Its Better Efficacy over Protopic Now Challenged
In response to a recent announcement by Novartis on citing the favorable results for its Elidel (pimecrolimus) Cream 1% over Protopic (tacrolimus) Ointment 0.03%, a counter statement was recently made by the maker of ...
KFDA Denies Its Upcoming Decision to Disapprove on ‘Bacchus-S’
Amid the continuing decision delays by the Korea Food and Drug Administration (KFDA) on the possible use of a trademark ‘Bacchus-S’, a quasi-medicine, requested by Dong-A Pharmaceutical, the KFDA made an official stat...
Kolmar Introduced Treatment for Atopic Dermatitis
Following the Korea Food and Drug Administration (KFDA)’s recent approval on pharmaceutical bioequivalence of the generic drugs, Korea Kolmar announced its successful development of a medication for treatment of atopi...
SK Chemical Officially Announces Its Merger Plan with SK Pharma
SK Chemical announced on December 23 that the company has declared an official merger plan with SK Pharma, via signing a contract with Samil PriceWaterhouseCoopers (PWC), a domestic affiliate of the international acco...
Domestic Ban on Sale of Celebrex Suggested by Pharmacist Group
In an official statement released on December 21st, the Korean Pharmacists for Democratic Society (KPDS) strongly suggested that Pfizer should withdraw Celebrex, a Cox-2 inhibitor for treatment of pain and inflammatio...
